Home > Press > Oxonica’s CEO Appointed to the Elementis Board
Oxonica Ltd announces today that its chief executive, Dr. Kevin Matthews has been appointed to the Board of Elementis plc, as a non-executive director with effect from 16th February 2005.
Oxonica’s CEO Appointed as a Non-executive Director to the Elementis Board
February 17, 2005
Oxonica Limited is a leading European technology group, with products already launched into the global market.
The company was spun-out in 1999 from the University of Oxford and is based in Oxford, England. Oxonica currently employs 30 professional staff and is lead by a strong and commercially experienced management team.
Oxonica’s mission is to develop commercial solutions from nanotechnology. It owns a diverse portfolio of demand driven products that offer substantial benefits to the target markets of environmental, healthcare and materials.
Lead products include:
- Envirox™ Fuel Borne Catalyst – A nanocataylst optimising fuel economy and reducing emissions
- Optisol™ UV Filter – A range of ultra-stable UVA absorbers with enhanced free radical scavenging, with immediate applications in sunscreens and other cosmetics
Oxonica is also active in searching for the next generation of products and is already engaged in developing transformational detection technologies which will enable a new generation of diagnostic products for the clinical diagnostic and life science markets.
In addition, the company is developing other UV absorber technologies into polymer systems and coatings, based on similar technologies to that used in Optisol™.
01865 856 728
Island House, Forest Road, Guernsey, GY8 0AB, UK
Tel +44 (0) 1481 233080
Fax +44 (0) 1481 233082
Copyright © Oxonica
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Nanoparticles Increase Durability of Concrete Decorations in Cold Areas January 26th, 2015
Iranian Researchers Boost Solar Cells Efficiency Using Anti-Aggregates January 26th, 2015
Detection of Heavy Metals in Samples with Naked Eye January 26th, 2015
Engineering self-assembling amyloid fibers January 26th, 2015
Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015
SUNY Board Appoints Dr. Alain Kaloyeros as Founding President of SUNY Polytechnic Institute January 13th, 2015
Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, to Board of Directors January 8th, 2015
QD Vision Receives New Funding Round to Meet Growing Demand for Quantum Dot Technology: Industry Veteran Steve Ward Named Executive Chairman January 5th, 2015